Mural Oncology Financial Ratios for Analysis 2022-2024 | MURA

Fifteen years of historical annual and quarterly financial ratios and margins for Mural Oncology (MURA).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
9.560.12
--
--
--
--
--
--
--
--
--
--
--
--
-78.63876
-78.63876
-68.75-562.39
-78.63876
15.81-
-11.64-10.10
-11.85-10.43

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
7.388.6511.279.560.19----
---------
---------
---------
---------
---------
---------
---------
---------
---------
---------
---------
---------
-18.24-15.43-13.16-22.57-----
-18.24-15.43-13.16-22.57744----
-15.62-13.44-11.73-19.73-169.79----
-18.24-15.43-13.16-22.57744----
10.2212.0913.8815.81-----
-5.68-3.94-2.22-11.64-9.08-6.05-3.340.00-7.83
-5.69-3.94-2.23-11.85-9.22-6.12-3.36--8.15